Abstract:Periodontal disease (Periodontitis) is a serious disease that affects a majority of adult Americans and is associated with other systemic diseases, including diabetes, rheumatoid arthritis, and other inflammatory diseases. While great efforts have been devoted toward understanding the pathogenesis of periodontitis, there remains a pressing need for developing potent therapeutic strategies for targeting this pervasive and destructive disease. In this study, we utilized novel adeno-associated virus (AAV)-mediated Atp6v1c1 knockdown gene therapy to treat bone erosion and inflammatory caused by periodontitis in mouse model. Atp6v1c1 is a subunit of the V-ATPase complex and regulator of the assembly of the V0 and V1 domains of the V-ATPase complex. We demonstrated previously that Atp6v1c1 has an essential function in osteoclast mediated bone resorption. We hypothesized that Atp6v1c1 may be an ideal target to prevent the bone erosion and inflammation caused by periodontitis. To test the hypothesis, we employed AAV RNAi knockdown of Atp6v1c1 gene expression to prevent bone erosion and gingival inflammation simultaneously. We found that lesion-specific injection of AAV-shRNA-Atp6v1c1 into the periodontal disease lesions protected against bone erosion (>85%) and gingival inflammation caused by P. gingivalis W50 infection. AAV-mediated Atp6v1c1 knockdown dramatically reduced osteoclast numbers and inhibited the infiltration of dendritic cells and macrophages in the bacteria-induced inflammatory lesions in periodontitis. Silencing of Atp6v1c1 expression also prevented the expressions of osteoclast-related genes and pro-inflammatory cytokine genes. Our data suggests that AAV-shRNA-Atp6v1c1 treatment can significantly attenuate the bone erosion and inflammation caused by periodontitis, indicating the dual function of AAV-shRNA-Atp6v1c1 as an inhibitor of bone erosion mediated by osteoclasts, and as an inhibitor of inflammation through down-regulation of pro-inflammatory cytokine expression. This study demonstrated that Atp6v1c1 RNAi knockdown gene therapy mediated by AAV-shRNA-Atp6v1c1 is a promising novel therapeutic approach for the treatment of bone erosion and inflammatory related diseases, such as periodontitis and rheumatoid arthritis.

Inhibition of Rgs10 Expression Prevents Immune Cell Infiltration in Bacteria-induced Inflammatory Lesions and Osteoclast-mediated Bone Destruction.

Inhibition of RGS10 Aggravates Periapical Periodontitis via Upregulation of the NF-κB Pathway

RGS10 negatively regulates apical periodontitis via TFEB-mediated autophagy in BABL/c mice model and in vitro

Role of OPG/RANKL/RANK system during alveolar bone resorption and remodeling

Author Response for "inhibition of Rgs10 Aggravates Periodontitis with Collagen-Induced Arthritis Via the Nuclear Factor-Kappa B Pathway"

Regulation of Osteoclast Differentiation and Inflammatory Signaling by TCF8 in Periodontitis.

Targeting Atp6v1c1 Prevents Inflammation and Bone Erosion Caused by Periodontitis and Reveals Its Critical Function in Osteoimmunology

Inhibition of regulator of G protein signaling 10, aggravates rheumatoid arthritis progression by promoting NF-B signaling pathway

HOXA10 Inhibit the Osteogenic Differentiation of Periodontal Ligament Stem Cells by Regulating Β-Catenin Localization and DKK1 Expression

RhoA Promotes Osteoclastogenesis and Regulates Bone Remodeling Through Mtor-Nfatc1 Signaling.

RGS1 silencing inhibits the inflammatory response and angiogenesis in rheumatoid arthritis rats through the inactivation of Toll‐like receptor signaling pathway

MiRNA-218 regulates osteoclast differentiation and inflammation response in periodontitis rats through Mmp9.

TLR2-dependent Modulation of Osteoclastogenesis by Porphyromonas Gingivalis Through Differential Induction of NFATc1 and NF-κB

Regulator of G Protein Signaling 12 Enhances Osteoclastogenesis by Suppressing Nrf2-dependent Antioxidant Proteins to Promote the Generation of Reactive Oxygen Species.

CXCR4 signaling contributes to alveolar bone resorption in Porphyromonas gingivalis-induced periodontitis in mice

A20 inhibits periodontal bone resorption and NLRP3-mediated M1 macrophage polarization

Epithelial RANKL Limits Experimental Periodontitis via Langerhans Cells

Ginsenoside Rb3 Inhibits Osteoclastogenesis Via ERK/NF‐κB Signaling Pathway in Vitro and in Vivo

A novel lncRNA-mediated epigenetic regulatory mechanism in periodontitis

Ginsenoside Rb3 Inhibits Pro-Inflammatory Cytokines via MAPK/AKT/NF-κB Pathways and Attenuates Rat Alveolar Bone Resorption in Response to Porphyromonas gingivalis LPS

Porphyromonas Gingivalis Exacerbates Ligature-Induced, RANKL-dependent Alveolar Bone Resorption Via Differential Regulation of Toll-like Receptor 2 (TLR2) and TLR4.